<SEC-DOCUMENT>0001140361-22-043937.txt : 20221201
<SEC-HEADER>0001140361-22-043937.hdr.sgml : 20221201
<ACCEPTANCE-DATETIME>20221201081201
ACCESSION NUMBER:		0001140361-22-043937
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221201
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221201
DATE AS OF CHANGE:		20221201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		221437409

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10044960_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:roiv="http://roivant.com/20221201" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit Financial
         Document created using Broadridge PROfile 22.10.2.5096
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_72daede305c84fe8a7a5730e0e707b89" contextRef="c20221201to20221201" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_c062787d921b420d8de3bb179f9e4828" contextRef="c20221201to20221201">0001635088</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="roiv-20221201.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20221201to20221201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001635088</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001635088</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001635088</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">roiv:RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, DC 20549</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_2e0a32e562b94cec97a2aa32144f8957" contextRef="c20221201to20221201">8-K</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section&#160;13 or 15(d)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_90c3f6909b2a4e24b87652c7ab244af9" contextRef="c20221201to20221201" format="ixt:date-monthname-day-year-en">December 1, 2022</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_58265e3943c341a9927d02930a9737be" contextRef="c20221201to20221201">Roivant Sciences Ltd.</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact Name of Registrant as Specified in Charter)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_a3c590d137aa4c9da3ae8a4a2ecdcb8e" contextRef="c20221201to20221201" format="ixt-sec:edgarprovcountryen">Bermuda</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_64aac78ef8e94f61bc0e89ce6475c007" contextRef="c20221201to20221201">001-40782</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 33.33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_13728d8a88964def90466eb762635e86" contextRef="c20221201to20221201">98-1173944</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(State or Other Jurisdiction of Incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Commission File Number)</div>
          </td>

    <td style="width: 33.33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(I.R.S. Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_84c02034eed34db4be7034e6a4b8f66b" contextRef="c20221201to20221201">7th Floor</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_eaee175dc3704497af0618afd4ab5920" contextRef="c20221201to20221201">50 Broadway</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_bea9eb89cee242119c1dd17ae696207d" contextRef="c20221201to20221201">London</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_df574fc42fc643958f2d97243599a878" contextRef="c20221201to20221201">SW1H 0DB</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_ed7418d7c3fa4649ada7fa7cd87867a7" contextRef="c20221201to20221201" format="ixt-sec:countrynameen">United Kingdom</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Address of Principal Executive Offices, and Zip Code)</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">+44 <ix:nonNumeric name="dei:CityAreaCode" id="Fact_6b6db4f808594fd59cd83fddc018c0a2" contextRef="c20221201to20221201">207</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_b516545c0272487ebc4bde205e62e495" contextRef="c20221201to20221201">400-3347</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registrant&#8217;s Telephone Number, Including Area Code</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="text-align: center; margin-right: 203.75pt; margin-left: 203.75pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160; <br />
      </div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style: italic;">see</span> General Instruction A.2. below):</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 28.05pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_1ee4f121f64c4214bdc8a3139a8e0cad" contextRef="c20221201to20221201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 27pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_380ed899749e4dfb9921f5656dc5dbfb" contextRef="c20221201to20221201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 27pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c3a5d6fd9be247d58333e1875b059dd4" contextRef="c20221201to20221201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 27pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_3f60e0f344af44399b68b20e6bbf4e64" contextRef="c20221201to20221201" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 31.66%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Title of each class</div>
            <div>
              <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;"><br />
          </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Trading</div>
            <div style="text-align: center;"><span style="font-weight: bold;">Symbol(s)</span> <br />
            </div>
          </td>

    <td style="width: 1.84%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;"><br />
          </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name of each exchange</div>
            <div style="text-align: center;"><span style="font-weight: bold;">on which registered </span><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 31.66%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_f5b9b27984284b848f3c4bd351e6ebb3" contextRef="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember">Common Shares, $0.0000000341740141 par value per share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_210b1593148945e69ab5962ce28502ac" contextRef="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember">ROIV</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1.84%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_fc8561c9ecbb440ca4318a2a9f171cb6" contextRef="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 31.66%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_9ec1697d2165478a89a3a4ae3ca5586e" contextRef="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember">Redeemable warrants, each whole warrant exercisable for one Common Share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_11769ef1c249452882162edbefd1c538" contextRef="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember">ROIVW</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 1.84%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_04638680f8c34918959b2cfb4620d38f" contextRef="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule
      12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_ced1ef6f8b584dc68bea2508539de3f6" contextRef="c20221201to20221201" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_3674698b6f7e4906bd6a72e6bc5592f1" contextRef="c20221201to20221201" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 7.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Regulation FD Disclosure.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On December 1, 2022, Roivant Sciences Ltd. (the &#8220;Company&#8221;) and Pfizer Inc. issued a press release announcing the formation of a new Vant to develop and commercialize
      PF-06480605 (now RVT-3101), a fully human monoclonal antibody targeting TL1A which is currently in Phase 2b development in ulcerative colitis. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Company expects that this collaboration will not impact the Company&#8217;s previously announced cash runway into the second half of calendar year 2025. The Company expects
      to hold an investor call to present the clinical data and development plans for RVT-3101 at a later date.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, or
      the Exchange Act, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, or the Securities Act. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference
      into any other filing with the U.S. Securities Exchange Commission, or the SEC, made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 63pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item&#160;9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: bold;">Exhibit<br />
                No. </span><br />
            </div>
          </td>

    <td style="width: 1.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;"><br />
          </td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center;"><span style="font-weight: bold;">Description of Exhibit </span><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">&#160;</div>
          </td>

    <td style="width: 1.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="text-align: center;"><a href="brhc10044960_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 1.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; margin-left: 7.5pt;">Roivant Sciences Ltd. Press Release, dated December 1, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">&#160;</div>
          </td>

    <td style="width: 1.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; margin-left: 7.5pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255); white-space: nowrap;">
            <div style="text-align: center;">104</div>
          </td>

    <td style="width: 1.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; margin-left: 7.5pt;">Cover Page Interactive Data File (embedded with Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned
      hereunto duly authorized.</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
            <div style="text-align: left; font-weight: bold;">ROIVANT SCIENCES LTD.</div>
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 35%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
            <div style="text-align: left;">By:</div>
          </td>

    <td style="width: 35%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Matt Maisak&#160; <br />
            </div>
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Name:</div>
          </td>

    <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Matt Maisak</div>
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Title:</div>
          </td>

    <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Authorized Signatory</div>
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 35%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>

  <tr>

    <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;" colspan="2">
            <div style="text-align: left;">Dated: December 1, 2022</div>
          </td>

    <td style="width: 60%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><br />
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>brhc10044960_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 22.10.2.5096
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div>
        <div>
          <div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 36pt; vertical-align: top; text-align: center;">&#8226;</td>
                  <td style="width: auto; vertical-align: top;">
                    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Roivant to develop PF-06480605 (now RVT-3101), a potential first in class, fully human monoclonal antibody that blocks tumor necrosis factor-like ligand
                      1A (TL1A), a cytokine believed to play a key role in inflammation and fibrosis&#160;&#160;</div>
                  </td>
                </tr>

            </table>
            <br>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zffa6ba0d0a134fe3b31d507d9576afd3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; text-align: center;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">RVT-3101 is currently being evaluated in a large global Phase 2b study (TUSCANY-2) with final results expected in 1H 2023</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">BASEL, Switzerland, LONDON, NEW YORK and BOSTON, December 1, 2022 (GLOBE NEWSWIRE) &#8212; Roivant Sciences (Nasdaq: ROIV) and Pfizer Inc. (NYSE: PFE) today announced
        formation of a new Vant to develop and commercialize PF-06480605 (now RVT-3101). RVT-3101 is a fully human monoclonal antibody targeting TL1A, which is currently in Phase 2b development in ulcerative colitis (UC).&#160;&#160;The <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Vant has</font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">the exclusive option to collaborate with Pfizer on a next-generation TL1A directed antibody
          which recently entered Phase 1.&#160; </font> &#160;&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">RVT-3101 is a potential first-in-class agent that targets both inflammatory and fibrotic pathways by inhibiting TL1A, which has been shown to modulate the location and
        severity of inflammation and fibrosis by stimulating TH1 and TH17 pathways, in addition to activating fibroblasts. As such, RVT-3101 has the potential to provide greater efficacy by hitting multiple inflammatory pathways as well as fibrotic
        pathways.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">RVT-3101 has been evaluated in an earlier Phase 2 study (TUSCANY) in 50 patients, and is being evaluated in a large global Phase 2b study (TUSCANY-2) in 245 adult
        participants with moderate to severe ulcerative colitis. The induction portion of TUSCANY-2 is complete, and the maintenance portion remains ongoing.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Our internally discovered antibody against TL1A, could potentially be the first agent to bring biomarker-selected precision medicine to people living with
        inflammatory bowel disease,&#8221; said Mikael Dolsten, Pfizer&#8217;s Chief Scientific Officer, President, Worldwide Research, Development and Medical.&#160;&#8220;We are very excited about the preliminary data from the TUSCANY-2 study and for this new Vant to drive the
        advancement of this asset. At the same time, it enables Pfizer to bring additional innovative breakthrough medicines and vaccines to patients in need more quickly, allowing us to serve more people.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We believe in RVT-3101&#8217;s potential to transform the inflammatory bowel disease landscape, which has long been in need of new, innovative therapies with greater
        efficacy,&#8221; said Mayukh Sukhatme, President and Chief Investment Officer of Roivant. &#8220;We are excited about this collaboration with Pfizer on a potential first-in-class program, which we intend to pursue in both ulcerative colitis and in additional
        inflammatory and fibrotic diseases. TUSCANY-2 builds on the earlier TUSCANY data with many firsts for the class &#8211; TUSCANY-2 is the first study with subcutaneous efficacy data and the first dose-ranging study &#8211; and is among the largest Phase 2b
        studies ever conducted in the indication. We are encouraged by the preliminary data and look forward to presenting our data and to seeing other results from the class.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Inflammatory bowel diseases are chronic inflammatory diseases of the gastrointestinal tract. It is estimated that up to 2 million US adults suffer from inflammatory
        bowel diseases, which include ulcerative colitis and Crohn&#8217;s disease. There is significant unmet treatment need for patients with inflammatory bowel disease. High rates of treatment failure mean that approximately 50% of patients are cycling off a
        given therapy within 6 to 12 months and are unlikely to achieve sustained remission. The commercial markets for these diseases for advanced therapies is nearly $15 billion per year in the US alone and growing.&#160; Available treatments have very low
        remission rates, and thus there is a large need for an efficacious and safe therapy.<br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Terms of Collaboration</font>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Hlk119868889"></a>A new Vant or Roivant subsidiary has been created to develop and fund these programs.&#160; The Vant will be fully responsible for funding
        global development of RVT-3101 in UC and in additional inflammatory and fibrotic diseases and holds commercial rights in the US and Japan. Pfizer owns a 25% equity position in the Vant and maintains commercial rights outside of the US and Japan as
        well as representation on the company&#8217;s Board of Directors.</div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Vant has the exclusive option to collaborate with Pfizer on a next-generation TL1A directed antibody which recently entered Phase 1. <a name="z_Int_TZEjUFm4"></a>The Vant will have the right to enter into an agreement for global development with a 50/50 cost share as well as co-commercialization rights with Pfizer prior to Phase 2 (expected in 2025).<font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</font></div>
      <div style="text-align: justify;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">About Roivant Sciences</font>&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
        </font>Roivant&#8217;s mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines faster by building technologies and developing talent in creative ways,
        leveraging the Roivant platform to launch Vants &#8211; nimble and focused biopharmaceutical and health technology companies. For more information, please visit<font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(5, 99, 193);">&#160;<font style="color: rgb(0, 0, 0);"><u>www.roivant.com</u></font></font><font style="color: rgb(0, 0, 0);">.</font>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">About Pfizer: Breakthroughs That Change Patients&#8217; Lives</font>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the
        standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness,
        prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world&#8217;s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments
        and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to
        investors on our website at <u>www.Pfizer.com</u>. In addition, to learn more, please visit us on <u>www.Pfizer.com</u>&#160; and follow us on Twitter at <u>@Pfizer</u> and <u>@Pfizer News</u>,
        <u>LinkedIn</u>, <u>YouTube</u> and like us on Facebook at <u>Facebook.com/Pfizer</u>.&#160;&#160;</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Roivant Sciences Forward-Looking Statements</font>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are
        considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which are usually identified by
        the use of words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and variations of such words or similar expressions.
        The words may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking
        statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act.&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Our forward-looking statements include, but are not limited to, statements regarding our or our management team&#8217;s expectations, hopes, beliefs, intentions or
        strategies regarding the future, and statements that are not historical facts, including statements about the clinical and therapeutic potential of our products and product candidates, the availability and success of topline results from our
        ongoing clinical trials and any commercial potential of our products and product candidates. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying
        assumptions, are forward-looking statements.&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Although we believe that our plans, intentions, expectations and strategies as reflected in or suggested by those forward-looking statements are reasonable,
        we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a number
        of risks, uncertainties and assumptions, including, but not limited to, those risks set forth in the Risk Factors section of our filings with the U.S. Securities and Exchange Commission. Moreover, we operate in a very competitive and rapidly
        changing environment in which new risks emerge from time to time. These forward-looking statements are based upon the current expectations and beliefs of our management as of the date of this press release, and are subject to certain risks and
        uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as required by applicable law, we assume no obligation to update publicly any forward-looking statements, whether as a
        result of new information, future events or otherwise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Pfizer Disclosure Notice</font>&#160;</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The information contained in this release is as of December 1, 2022. Pfizer assumes no obligation to update forward-looking statements contained in this release as the
        result of new information or future events or developments.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This release contains forward-looking information about, among other things, PF-06480605 (now RVT-3101), an additional antibody asset<font style="font-size: 12pt; font-family: 'Times New Roman';">&#160;</font>and a collaboration between Pfizer and Roivant and a new biopharmaceutical company, including their potential benefits, that involves substantial risks and uncertainties that could cause actual results to
        differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints,
        commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the
        risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from the clinical studies; whether and when any
        applications may be filed for any potential indications for PF-06480605/RVT-3101 or the additional antibody asset in any jurisdictions; whether and when regulatory authorities may approve any such applications that may be filed for
        PF-06480605/RVT-3101 or the additional antibody asset, which will depend on myriad factors, including making a determination as to whether the product&#8217;s benefits outweigh its known risks and determination of the product&#8217;s efficacy and, if approved,
        whether PF-06480605/RVT-3101 or the additional antibody asset will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or
        commercial potential of PF-06480605/RVT-3101 or the additional antibody asset; whether the collaboration with Roivant will be successful; uncertainties regarding the impact of COVID-19 on Pfizer&#8217;s business, operations and financial results; and
        competitive developments.</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">A further description of risks and uncertainties can be found in Pfizer&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in its subsequent
        reports on Form 10-Q, including in the sections thereof captioned &#8220;Risk Factors&#8221; and &#8220;Forward-Looking Information and Factors That May Affect Future Results&#8221;, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S.
        Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.</div>
      <div>&#160;</div>
      <div> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>&#160;</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>roiv-20221201.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<xs:schema targetNamespace="http://roivant.com/20221201" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:roiv="http://roivant.com/20221201" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="roiv-20221201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="roiv-20221201_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="roiv-20221201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://roivant.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" id="roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>roiv-20221201_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://roivant.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="roiv-20221201.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://roivant.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="definition: ClassOfStockDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="roiv-20221201.xsd#roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:label="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:title="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:title="definition: ClassOfStockDomain to RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>roiv-20221201_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="roiv-20221201.xsd#roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:label="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:title="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" />
    <link:label xlink:type="resource" xlink:label="roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember_lbl1" xml:lang="en-US" id="roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember_lbl1">Redeemable warrants, each whole warrant exercisable for one Common Share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:to="roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember_lbl1" xlink:title="label: RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember to roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>roiv-20221201_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.10.2.5096 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://roivant.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="roiv-20221201.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://roivant.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonStockMember" xlink:title="presentation: ClassOfStockDomain to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="roiv-20221201.xsd#roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:label="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:title="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" xlink:title="presentation: ClassOfStockDomain to RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140058688304448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Roivant Sciences Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001635088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">D0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1173944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">50 Broadway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">London<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">SW1H 0DB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">400-3347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, $0.0000000341740141 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ROIV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember', window );">Redeemable warrants, each whole warrant exercisable for one Common Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, each whole warrant exercisable for one Common Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ROIVW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc10044960_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:roiv="http://roivant.com/20221201"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="roiv-20221201.xsd" xlink:type="simple"/>
    <context id="c20221201to20221201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001635088</identifier>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-01</endDate>
        </period>
    </context>
    <context id="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001635088</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-01</endDate>
        </period>
    </context>
    <context id="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001635088</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">roiv:RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20221201to20221201"
      id="Fact_72daede305c84fe8a7a5730e0e707b89">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20221201to20221201"
      id="Fact_c062787d921b420d8de3bb179f9e4828">0001635088</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20221201to20221201"
      id="Fact_2e0a32e562b94cec97a2aa32144f8957">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20221201to20221201"
      id="Fact_90c3f6909b2a4e24b87652c7ab244af9">2022-12-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20221201to20221201"
      id="Fact_58265e3943c341a9927d02930a9737be">Roivant Sciences Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20221201to20221201"
      id="Fact_a3c590d137aa4c9da3ae8a4a2ecdcb8e">D0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20221201to20221201"
      id="Fact_64aac78ef8e94f61bc0e89ce6475c007">001-40782</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20221201to20221201"
      id="Fact_13728d8a88964def90466eb762635e86">98-1173944</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20221201to20221201"
      id="Fact_84c02034eed34db4be7034e6a4b8f66b">7th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20221201to20221201"
      id="Fact_eaee175dc3704497af0618afd4ab5920">50 Broadway</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20221201to20221201"
      id="Fact_bea9eb89cee242119c1dd17ae696207d">London</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20221201to20221201"
      id="Fact_df574fc42fc643958f2d97243599a878">SW1H 0DB</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="c20221201to20221201"
      id="Fact_ed7418d7c3fa4649ada7fa7cd87867a7">GB</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="c20221201to20221201"
      id="Fact_6b6db4f808594fd59cd83fddc018c0a2">207</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20221201to20221201"
      id="Fact_b516545c0272487ebc4bde205e62e495">400-3347</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20221201to20221201"
      id="Fact_1ee4f121f64c4214bdc8a3139a8e0cad">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20221201to20221201"
      id="Fact_380ed899749e4dfb9921f5656dc5dbfb">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20221201to20221201"
      id="Fact_c3a5d6fd9be247d58333e1875b059dd4">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20221201to20221201"
      id="Fact_3f60e0f344af44399b68b20e6bbf4e64">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_f5b9b27984284b848f3c4bd351e6ebb3">Common Shares, $0.0000000341740141 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_210b1593148945e69ab5962ce28502ac">ROIV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20221201to20221201_StatementClassOfStockAxis_CommonStockMember"
      id="Fact_fc8561c9ecbb440ca4318a2a9f171cb6">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember"
      id="Fact_9ec1697d2165478a89a3a4ae3ca5586e">Redeemable warrants, each whole warrant exercisable for one Common Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember"
      id="Fact_11769ef1c249452882162edbefd1c538">ROIVW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20221201to20221201_StatementClassOfStockAxis_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember"
      id="Fact_04638680f8c34918959b2cfb4620d38f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20221201to20221201"
      id="Fact_ced1ef6f8b584dc68bea2508539de3f6">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20221201to20221201"
      id="Fact_3674698b6f7e4906bd6a72e6bc5592f1">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M@$&!59SY(^$<!0  N!8  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RM
MF&]OXC@0QK^*Q9U.=U);G 0*[0$2I>TNVO[A2F\KW>I>F&0 JTF<M4UIO_V-
M R5L-TRXJGU1DF __#(>/V.[LU3ZT<P!+'M.XM1T:W-KL]-ZW81S2(0Y4AFD
M^,U4Z418O-6SNLDTB"COE,1UG_/C>B)D6NMU\F<CW>NHA8UE"B/-S"))A'XY
M@U@MNS6O]OK@3L[FUCVH]SJ9F,$8[-_92.-=?:,2R012(U7*-$R[M;YW>A8$
MKD/>XJN$I=FZ9NY5)DH]NIMAU*UQ1P0QA-9)"/QX@@'$L5-"CN]KT=KF-UW'
M[>M7]<O\Y?%E)L+ 0,4/,K+S;JU=8Q%,Q2*V=VKY&=8OU'1ZH8I-_I\MUVUY
MC84+8U6R[HP$B4Q7G^)Y'8BM#JU@1P=_W<'/N5<_E%.>"RMZ':V63+O6J.8N
M\E?->R.<3-VHC*W&;R7VL[US%2XPR):)-&(7J97VA0W3U6ACU#IUBS_BFM;#
MM>#92M#?)0CA$>/> ?.Y[__8O8YL&T!_ ^CG>L$.O373E316IC/#OEUA S:T
MD)A_R^A6:HUR-9?CIR83(71KF,0&]!/4>K_]XAWS/PG68,,:4.I%,.]?,BB#
MH[NW#[\0$(T-1(-4Z2-!E%-<QF)61D'WGXK8 ,'1W' T]PO&"+14+KDBABE:
M&I<*)9=2>4Y5)=7QANV85%PGU:6,@=TLD@GH,BI:@W/OL,%;;8JGM>%I[<-S
M!S-,<RTP:#<B*8T4K7.GY)/K/0XEI"$8=F6C(X*OO>%K[\,WP.'4(D:#B."9
M?8&7,D):B6/8CH,F;[<)K),-ULD^6,,T5#I3.G>L S:VF&5,:390"^1%;!65
MQI(6/^<$H<<+?^7[,-Z+9S:,,'YR*L,<E$B\"LF3]J'GM8*31H,BW*H WCZ$
M_2A"1S0'KQ<L-]K;M#1T%9(M.T?W44I3@$4%\$C3I@'OEZH4D)9L<G:FE8B6
MXH5"+(S?HZW[+>+ W6$*WJME>0VEY:Y4&KTMOC^2%=7 H^W\)[+5I"B%HI4^
MG5% 15GP:#=_"S12QJ*G_".SG1.U0G'\X'UF_)S$*RJ#1]MZ/G)]7.#NIJ$%
M?-ZB0(J2X-%>?J5"#,MHKE*J1E6(-#@_#((&2504 6^O*G"1@)[A6HQ]0@6<
MZ .59"(MSRA:T.H%M=+PBCK@[54(+I[9/59/(W-_7:T[2K%HM0HLO_!^GS;J
M!RVMA=1%*%FD:]\WI:M66JAJ3>879N_3SCQ6L0RE6TJS:RR36HJXE(=6J>39
M6MW31CS2<!AB>-QR9;5TQM4K:'8[G98G?(5>)5EAZ3[MP3^1#8U9(%DE("U;
M"5@XNT_[L<LJ3/.Q5>$C^W8-SB+*MT2DSCOW1'YA^'[S8W=PI-N_%[<H #[M
MW_?2XJY 39GG_S[Y@XTA7. T+K6W"J77 9H+Y#Q@O_(COOH+&EZKP;V&QS*A
MV9.(%\ RS"GC6E(O410/G_9]M,'(S?'Q2S)1Y3.\8B=Q._Q*D11%PZ<]_C5^
M:,[A7*0SV+FUJ1"ZZ8_/^W]13$6Y\&F#OX,((!$3'.>ET&Z_A<,#(IRSY5P5
M#QD\@PZER1M.<37G2O'VH-*SCF1X[TE$47L"_J&S+B KT'MQB[H4T!7E?\RZ
M"J6/&ESJM8KR%M#EJ'H>5@BX>?A H6R=3=&%9_^)6"&T>R+6M\XAW9GNM7 +
M1<-BF*(2/VJAL^O5,>GJQJHL/YJ<*&M5DE_.06!Y=0WP^ZE2]O7&G79N#JM[
M_P%02P,$%     @ @$&!59^@&_"Q @  X@P   T   !X;"]S='EL97,N>&UL
MW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75E
MW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R
M5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#
M7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%
M8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE
M+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8
M Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL
M_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2S
MP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DM
MC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?
M7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D
M7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$
MKQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3
M\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q
M;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X
M#SY['R73>RHY_U=3_ 102P,$%     @ @$&!59>*NQS     $P(   L   !?
M<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^O
MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ @$&!50=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " " 08%56(WUK^T    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" " 08%5F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( (!!@56<^2/A' 4  +@6   8
M      " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" " 08%5GZ ;\+$"  #B#   #0              @ %>#0  >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( (!!@567BKL<P    !,"   +              "
M 3H0  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( (!!@54<.&7J/P$  #P"   /
M              "  2,1  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "
M08%5)!Z;HJT   #X 0  &@              @ &/$@  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " " 08%599!YDAD!  #/ P  $P
M            @ %T$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  "^%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10044960_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://roivant.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10044960_8k.htm">brhc10044960_8k.htm</File>
    <File>brhc10044960_ex99-1.htm</File>
    <File>roiv-20221201.xsd</File>
    <File>roiv-20221201_def.xml</File>
    <File>roiv-20221201_lab.xml</File>
    <File>roiv-20221201_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10044960_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "roiv-20221201_def.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10044960_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "roiv-20221201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "roiv-20221201_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "roiv-20221201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "roiv",
   "nsuri": "http://roivant.com/20221201",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10044960_8k.htm",
      "contextRef": "c20221201to20221201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://roivant.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10044960_8k.htm",
      "contextRef": "c20221201to20221201",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "roiv_RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable warrants, each whole warrant exercisable for one Common Share [Member]"
       }
      }
     },
     "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneCommonShareMember",
     "nsuri": "http://roivant.com/20221201",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://roivant.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-22-043937-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-043937-xbrl.zip
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M 91K!M;7F!DZON8'!K6$806>Z]@&<VE@6!8-GQO1X=!Z ]8+>1=):' Z:HR
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MLP(N#,T6CB$LWUZ"%$O3&J9IS=#S!I,QB:W]XQ?/T-V/&;D5D>CCT$O MH<
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M3RTEZBCJNQ23PS%6)3?P/<V3=+25EPT *C_^B.2[F+N53=A+\7[QD^*\_?S
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MLD)RD]89:8,T!O;1L(!6S!966^IJ12ZVDRO0I!!)3H/QK#^,^'O\?-BLK,<
MC, ;S '$!J# #_! 8VR]L@-Q:H6MDUFO=4=:.2VQE1>1F=(L= HLYPR_%&HR
M0?A)5K28F:YX7*RHTG-F.I'@&EEAV"7H /T,@FQW'NX:? /6TJBN&\WP69:@
M=V5 F;5 =I?N.AS25@"[%51 6B%]_9'0B)L/[A]"E1!N+"X*_QH)(HR5O1O6
MI=C7H2PV([4%] :"0$X7:9VP7<Q-&1"]F9(Q%;EGIBKEMD#&D$L-CZ=*D&J>
M*A5=M4"4J<$.OZ+JF$$-C]_4I:!EEH@<P*A4V\0L&*::,"*GM.3*NVIBZBQM
M#9UI#&_7I10>&(P8EZ3!L<8"RFM5]JW*'%+. 8C:DC!RE4(A!<M_K@RY0:87
M]!BII]5<QS?&!AY!ZZ3,O,>[&!T+*W4J?M+7$M^=F<QB=3V/WASA'QY;\7RF
MU<0%> @-D/2&'%*5N!$,"IY:5#WQWI19NB2WO5"8HB0W/XL"(RGW)UJWS)I(
MR()\KX2$ 4%V*XHMFH/"V-25 X8264X.MH9O4UDA=I<FYV]:(W*&S+"%_*J:
MP:@ZC*$DJ\0CK6!DNB#KXH7!'OD1H+.J@%%N7BMS/ -S +A5B$!$Y&P(:XV6
M NC!K318S,(YP!BX=5W-2E-/9XVN+"]P(1/W@33G?9?<KE#8-;)#)7ZK=7*=
MK> -66:6-$EMG9^5&)IO<2H?>!5^=4]XWZ2BM). ;(WU=*"]*F5AB=VQD'?;
MIR".:A,Y5W&, TV;.K0,(H/RH.I>+'T,7,JY5AZK?!!I=1^BR9H+R%5]/1.7
M^)^L2.N-:;/>G N\+!;*5FPUW@5H 9X!#T37H-=MF:$NT"3RX@VBM),T("!.
M2YD'42P5(T_A,O^ZM#5+GGG$%O+)D:&(;'4'0'18A]<#H7CC9^-:9RE!,"LO
M!"C_O?-.%QZHE,A;L-XCE<NR7=( D7<"0(N!SI%Y#%N/D[J2A3(P_X8 \!PA
M3+AG4F-5'U8U)5=Q X19?$B4.9D-$R&*@W@FA,"(#.%!,AD*9A <!RT7/9V=
M$FZ1\ 8B:+< GI< [918R5:DHNDS8ZY)!DM9.FW!JDC'6! >C_9##LZAVY#]
M-IEI@W8LOZ_O\B]W>JQEL21 O0+FTS&LY@Z&6A 1L,'2D EC'82=0(4$_O.R
M(G71Q9RY"[/D>D[".1!89$9>\_.EXR=$)2<3B(I%%,_7:K6[P":/*Y# I-LH
MBW/UTLR*!KW\PTQFL#_<8R%#BH(47>HB5_!M@AA&!<8D,OD&V]F8=^/<0/R@
M$22(3#GQ-$--I,YJS)@K63A)R#EPX /+!N3A</@]/=!,Q-)?)1G;T 19<RN&
M*;98>%QT[@6[?D!B'1U0_EO-W,YIB+J@>B3&9QH_8U2WL!<P&6P-+$Q;RWY
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MJJ^.]S._>-LL?A!MQ.'XQBCD':&>VS[HZZ5PUL(@G=/D(@P\!/--K;.UO83
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MRCZS>G^+?ZSL:[X]^9G9[]./_&VKK_]<^WOX[62?P@3_XO]$X/\"4$L#!!0
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MWX]1^OU,_)@""CN\WI2>K2D:=1>,+<]\_^GIJ?<T[&$R]X-^?^#_\^7J+ES
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M=W0'3")(Y#+D[=F<\XHC4?EE#.8&'&N93,TH:R^>LB1J\C$L)*"@&4"J<]Q
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M:\OOXI_8;(Z+'^*?OGSX'U!+ P04    " " 08%5HL059GT*  !M;@  %0
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M>\F[WK6^E*)?Z/-@C_!6=PR\P.LK;+NZ%[_% "_M9:>.\;TG2>I'?X7/QE^
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MXKH/_P-02P$"% ,4    " " 08%5--!;@!85  !=E@  $P
M@ $     8G)H8S$P,#0T.38P7SAK+FAT;5!+ 0(4 Q0    ( (!!@55G8JJ6
MG18  "M0   7              "  4<5  !B<FAC,3 P-#0Y-C!?97@Y.2TQ
M+FAT;5!+ 0(4 Q0    ( (!!@564>QN0T@,  #01   1              "
M 1DL  !R;VEV+3(P,C(Q,C Q+GAS9%!+ 0(4 Q0    ( (!!@56MLNA+(@<
M $!'   5              "  1HP  !R;VEV+3(P,C(Q,C Q7V1E9BYX;6Q0
M2P$"% ,4    " " 08%5HL059GT*  !M;@  %0              @ %O-P
M<F]I=BTR,#(R,3(P,5]L86(N>&UL4$L! A0#%     @ @$&!599D(<PM!P
M!%   !4              ( !'T(  ')O:78M,C R,C$R,#%?<')E+GAM;%!+
4!08     !@ & (X!  !_20     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
